Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Chemed Corp Reaffirms FY 2013 EPS Guidance-Conference Call


Friday, 19 Apr 2013 10:00am EDT 

Chemed Corp announced that the management estimates fiscal 2013 earnings per diluted share (EPS), excluding non-cash expense for stock options, non-cash interest expense related to accounting for convertible debt, and other items not indicative of ongoing operations, will be in the range of $5.65 to $5.80 According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $5.70 for fiscal 2013. 

Company Quote

108.43
1.22 +1.14%
24 Nov 2014